Home Health Business Quarterly

Blood thinning agent approved

For the first time, the U.S. Food & Drug Administration has approved a blood-thinning agent for the prevention of blood clots know as deep-vein thrombosis.

Lovenox, a low-molecular weight heparin from Aventis Pharmaceuticals in Parsippany, NJ, was approved for patients with restricted mobility at risk for thromboembolic complications from illnesses such as heart failure, respiratory failure, severe infection, back pain, vertebral compression, and arthritic episodes.